683 Capital Management Maintains Holding in Medicines Co (MDCO); Goldman Sachs Group (GS) Holding Maintained by Grand Jean Capital Management Inc

June 14, 2018 - By Ellis Scott

The Goldman Sachs Group, Inc. (NYSE:GS) Logo

Grand Jean Capital Management Inc increased its stake in Goldman Sachs Group (GS) by 9.52% based on its latest 2018Q1 regulatory filing with the SEC. Grand Jean Capital Management Inc bought 3,230 shares as the company’s stock declined 13.36% with the market. The institutional investor held 37,143 shares of the finance company at the end of 2018Q1, valued at $9.36M, up from 33,913 at the end of the previous reported quarter. Grand Jean Capital Management Inc who had been investing in Goldman Sachs Group for a number of months, seems to be bullish on the $88.28 billion market cap company. The stock decreased 0.05% or $0.11 during the last trading session, reaching $233.72. About 2.01 million shares traded. The Goldman Sachs Group, Inc. (NYSE:GS) has risen 5.64% since June 14, 2017 and is uptrending. It has underperformed by 6.93% the S&P500. Some Historical GS News: 30/04/2018 – Goldman’s Solomon Sees Greed Trumping Fear in Markets (Video); 17/04/2018 – Wall St extends rally after Goldman earnings beat forecasts; 04/05/2018 – Coeur to Participate in Goldman Sachs’ Leveraged Finance Conference; 29/05/2018 – Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co; 15/05/2018 – Circle raises $110 mln, plans to create dollar-pegged cryptocurrency; 08/05/2018 – FORMER TRUMP ADVISER, GOLDMAN PRESIDENT COHN SPEAKS ON CNBC; 30/04/2018 – BlackRock Hires Two Goldman Sachs Executives for Private Equity; 16/03/2018 – Goldman Sachs Reveals Yawning U.K. Gender Pay Gap; 24/04/2018 – New York Post: Goldman predicts the world’s first trillionaire will mine asteroids; 15/05/2018 – Goldman Sachs Group Buys New 1.2% Position in Avaya Holdings

683 Capital Management Llc increased its stake in Medicines Co (MDCO) by 134.5% based on its latest 2018Q1 regulatory filing with the SEC. 683 Capital Management Llc bought 67,252 shares as the company’s stock rose 4.51% while stock markets declined. The hedge fund held 117,252 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $3.86M, up from 50,000 at the end of the previous reported quarter. 683 Capital Management Llc who had been investing in Medicines Co for a number of months, seems to be bullish on the $2.70B market cap company. The stock increased 0.52% or $0.19 during the last trading session, reaching $36.63. About 289,933 shares traded. The Medicines Company (NASDAQ:MDCO) has declined 16.45% since June 14, 2017 and is downtrending. It has underperformed by 29.02% the S&P500. Some Historical MDCO News: 15/05/2018 – Medicines Co Closes Above 200-Day Moving Average: Technicals; 12/03/2018 – Chronicled Releases 2017 Progress Report for Blockchain Platform for Track-and-Trace of Prescription Medicines; 27/04/2018 – EU MEDICINES AGENCY RECOMMENDATIONS FOR APRIL 2018; 27/03/2018 – MEDICINES – ON MARCH 21, BOARD APPOINTED CHRISTOPHER VISIOLI CFO AND TREASURER OF COMPANY, EFFECTIVE IMMEDIATELY; 23/05/2018 – BSE Mumbai Bourse: Results from Kashyap Tele-Medicines for Apr 01 to Mar 31; 23/03/2018 – EU MEDICINES AGENCY RECOMMENDS AGAINST APPROVAL OF PORTOLA PHARMACEUTICALS’ PTLA.O DRUG FOR PREVENTING BLOOD CLOTS BETRIXIBAN; 23/04/2018 – MLNT PRESENTS DATA ON VABOMERE TANGO II IN VULNERABLE PATIENTS; 03/04/2018 – ASTRAZENECA PLC – EUROPEAN MEDICINES AGENCY ACCEPTS REGULATORY SUBMISSION FOR LYNPARZA IN BRCA-MUTATED, HER2-NEGATIVE METASTATIC; 02/05/2018 – The Medicines Patent Pool Adds New Suppliers from South Africa and South Korea to its Growing Generic Manufacturing Network; 07/05/2018 – The Medicines Company Announces lnclisiran Data Showing Significant Reductions in Potentially Harmful Subtypes of Bad Cholesterol (Atherogenic Lipoproteins) Linked to Heart Attack and Stroke

Investors sentiment decreased to 1.02 in Q1 2018. Its down 0.23, from 1.25 in 2017Q4. It fall, as 30 investors sold MDCO shares while 51 reduced holdings. 25 funds opened positions while 58 raised stakes. 91.05 million shares or 1.80% more from 89.44 million shares in 2017Q4 were reported. Fmr Limited Liability Com owns 10.99 million shares. 23,600 are held by Advisors Asset Mngmt. New York-based Amalgamated State Bank has invested 0.01% in The Medicines Company (NASDAQ:MDCO). Three Bays Limited Partnership has 3.96% invested in The Medicines Company (NASDAQ:MDCO). 82,227 were accumulated by University Of Notre Dame Du Lac. Virginia Retirement Et Al reported 0.02% stake. Deutsche Bancshares Ag has invested 0% of its portfolio in The Medicines Company (NASDAQ:MDCO). Balyasny Asset Mngmt Limited Company stated it has 0.02% in The Medicines Company (NASDAQ:MDCO). Invesco Limited holds 301,261 shares or 0% of its portfolio. Proshare Advisors Ltd Liability Corp has invested 0.01% in The Medicines Company (NASDAQ:MDCO). Citadel Advsr Limited Liability Company holds 0% or 21,707 shares in its portfolio. Iridian Asset Mgmt Lc Ct has invested 0.64% in The Medicines Company (NASDAQ:MDCO). Jpmorgan Chase stated it has 0% of its portfolio in The Medicines Company (NASDAQ:MDCO). Schwab Charles Inv reported 336,644 shares. Maverick Capital Limited reported 0.39% in The Medicines Company (NASDAQ:MDCO).

Among 12 analysts covering The Medicines Co (NASDAQ:MDCO), 12 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. The Medicines Co had 38 analyst reports since August 28, 2015 according to SRatingsIntel. RBC Capital Markets maintained the shares of MDCO in report on Tuesday, November 8 with “Outperform” rating. Oppenheimer maintained the stock with “Hold” rating in Wednesday, July 12 report. The stock has “Buy” rating by Cowen & Co on Wednesday, August 9. As per Tuesday, October 10, the company rating was maintained by Cowen & Co. As per Wednesday, August 30, the company rating was maintained by Chardan Capital Markets. Citigroup maintained The Medicines Company (NASDAQ:MDCO) rating on Monday, August 14. Citigroup has “Neutral” rating and $44 target. The rating was maintained by Jefferies with “Buy” on Wednesday, August 2. The rating was maintained by Oppenheimer with “Buy” on Monday, January 15. The company was maintained on Wednesday, July 26 by Citigroup. The rating was maintained by Citigroup with “Neutral” on Monday, July 17.

683 Capital Management Llc, which manages about $566.08M and $1.13 billion US Long portfolio, decreased its stake in Adma Biologics Inc (NASDAQ:ADMA) by 145,000 shares to 805,000 shares, valued at $3.70M in 2018Q1, according to the filing. It also reduced its holding in Herbalife Ltd (Put) (NYSE:HLF) by 50,000 shares in the quarter, leaving it with 300,000 shares, and cut its stake in Kkr & Co LP Del (NYSE:KKR).

More recent The Medicines Company (NASDAQ:MDCO) news were published by: Seekingalpha.com which released: “Premarket analyst action – healthcare” on June 07, 2018. Also Seekingalpha.com published the news titled: “Rounds Report: Melinta Rallied While The FDA Approved OsteoDetect” on May 26, 2018. Seekingalpha.com‘s news article titled: “Rounds Report: Melinta Rallied While Novavax Experienced Significant Insider Purchases” with publication date: June 06, 2018 was also an interesting one.

Since December 15, 2017, it had 0 insider buys, and 3 selling transactions for $1.06 million activity. Spigelman Melvin K had sold 7,500 shares worth $241,500 on Friday, May 25. KESSLER ARMIN M also sold $574,200 worth of The Medicines Company (NASDAQ:MDCO) shares. On Friday, December 15 the insider MEANWELL CLIVE sold $3.71M.

Investors sentiment increased to 1.16 in 2018 Q1. Its up 0.17, from 0.99 in 2017Q4. It increased, as 61 investors sold GS shares while 357 reduced holdings. 140 funds opened positions while 345 raised stakes. 266.01 million shares or 1.06% less from 268.85 million shares in 2017Q4 were reported. Stifel Finance owns 151,096 shares or 0.12% of their US portfolio. Dowling Yahnke Lc reported 24,463 shares. Scotia Cap holds 0.12% or 35,397 shares. Thompson Siegel & Walmsley Ltd Llc has 264 shares for 0% of their portfolio. Boys Arnold & has invested 0.03% in The Goldman Sachs Group, Inc. (NYSE:GS). Archford Cap Strategies Ltd Limited Liability Company invested in 0% or 24 shares. Hanson Doremus Invest Management accumulated 925 shares or 0.07% of the stock. Badgley Phelps Bell reported 0.01% stake. Fmr Ltd Com holds 8.98 million shares. Bluecrest Cap Mgmt reported 0.12% stake. Hyman Charles D reported 0.08% of its portfolio in The Goldman Sachs Group, Inc. (NYSE:GS). Guardian Life Insur Of America reported 807 shares or 0.04% of all its holdings. First Midwest Bank & Trust Tru Division owns 873 shares or 0.03% of their US portfolio. Fincl Prns Mgmt Llc reported 23,030 shares stake. Blair William Communications Il, a Illinois-based fund reported 513,238 shares.

Among 32 analysts covering Goldman Sachs Group Inc. (NYSE:GS), 14 have Buy rating, 1 Sell and 17 Hold. Therefore 44% are positive. Goldman Sachs Group Inc. had 109 analyst reports since July 21, 2015 according to SRatingsIntel. Oppenheimer maintained the stock with “Outperform” rating in Friday, January 29 report. The firm has “Neutral” rating by Instinet given on Tuesday, November 29. As per Thursday, January 18, the company rating was maintained by RBC Capital Markets. Wells Fargo maintained The Goldman Sachs Group, Inc. (NYSE:GS) rating on Thursday, March 22. Wells Fargo has “Buy” rating and $330.0 target. The stock of The Goldman Sachs Group, Inc. (NYSE:GS) earned “Hold” rating by Berenberg on Wednesday, July 13. The stock of The Goldman Sachs Group, Inc. (NYSE:GS) has “Neutral” rating given on Friday, October 16 by UBS. The firm has “Hold” rating by BMO Capital Markets given on Tuesday, October 17. The stock has “Overweight” rating by Morgan Stanley on Friday, February 2. The firm has “Market Perform” rating given on Wednesday, July 19 by Wood. UBS upgraded The Goldman Sachs Group, Inc. (NYSE:GS) on Friday, February 5 to “Buy” rating.

Grand Jean Capital Management Inc, which manages about $351.43M and $264.19 million US Long portfolio, decreased its stake in Comcast Corp (NASDAQ:CMCSA) by 88,489 shares to 297,241 shares, valued at $10.16 million in 2018Q1, according to the filing. It also reduced its holding in Alphabet Inc Class A (NASDAQ:GOOGL) by 827 shares in the quarter, leaving it with 1,311 shares, and cut its stake in Apple Computer (NASDAQ:AAPL).

The Medicines Company (NASDAQ:MDCO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.